Amphetamine News and Research

RSS

OnDosis and Adare Pharma Solutions Announce Strategic Collaboration to Advance OnDosis's Lead U.S. ADHD Program

OnDosis and Adare Pharma Solutions Announce Strategic Collaboration to Advance OnDosis's Lead U.S. ADHD Program

OnDosis AB ("OnDosis"), a Swedish life science company developing drug device combinations for precision dosing of oral solid medicines based on the Dosage Manager device platform, and Adare Pharma Solutions ("Adare"), a technology-driven, integrated contract development and manufacturing organization (CDMO), today announced a strategic collaboration.

From OnDosis AB 1 Oct 2026

C. elegans Study Reveals Impact of Embryonal Amphetamine Exposure

C. elegans Study Reveals Impact of Embryonal Amphetamine Exposure

Amphetamine is a psychostimulant that has been used to treat a variety of brain dysfunctions. However, it is a highly abused drug.

31 May 2024

Researchers describe two new fungal species

Researchers describe two new fungal species

University of Copenhagen researchers have found and described two fungal species for the first time. The fungi infect adult flies and subsequently create a hole in the abdomen of their hosts' bodies.

16 Dec 2020

New weight loss amphetamine could avoid side effects of older treatments

New weight loss amphetamine could avoid side effects of older treatments

Researchers developed a new weight loss amphetamine that could potentially avoid the side effects of older treatments.

14 May 2020

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.